Breaking Nephrology | Physician's Weekly

Breaking Nephrology

Presentation of Multisystem Inflammatory Syndrome Varies in Adults

May 21, 2021

THURSDAY, May 20, 2021 (HealthDay News) — Patients with multisystem inflammatory syndrome in...

Smartphone App Improves Kidney Transplant Outcomes

May 17, 2021

FRIDAY, May 14, 2021 (HealthDay News) — A pharmacist-led smartphone health app prevents...

Assessing Pediatric Immunization Practices in Nephrotic Syndrome

May 10, 2021

In the current era of the COVID-19 pandemic, understanding barriers to vaccinations in...

Dapagliflozin Gets FDA Nod For Treatment of CKD

May 4, 2021

New indication expands the use of the oral diabetes drug Dapagliflozin (Farxiga) won FDA approval for use for patients with chronic kidney disease who are at risk of disease progression. The oral tablets showed efficacy in a...

Transient Improvement Found in Sedentary Time in CKD With Intervention

Apr 27, 2021

MONDAY, April 26, 2021 (HealthDay News) — An intervention to reduce sedentary time and...

Assessing the Associations Between Blood Pressure Variability, Diuretics & Cardiovascular Events in Patients With CKD

Apr 21, 2021

“Patients with CKD have disproportionately high cardiovascular (CV) risk,” explains L. Parker...

Mortality Risk Up for Dialysis Patients in March to July 2020

Apr 10, 2021

FRIDAY, April 9, 2021 (HealthDay News) — Patients undergoing dialysis and those with kidney...

Hope for PH1 Patients: Investigational Lumasiran Normalizes Urinary Oxalate Excretion

Apr 2, 2021

ILLUMINATE-A study results show efficacy, safety of lumasiran in patients with primary hyperoxaluria type 1 (PH1) In patients with primary hyperoxaluria type 1 (PH1), treatment with lumasiran—an RNA interference...